Hoffmann-La Roche, Inc.

Facebook Twitter Google+ LinkedIn
Hoffmann-La Roche, Inc. - Hoffmann-La Roche is the US prescription pharmaceuticals unit of Roche Group, which operates businesses ranging from pharmaceuticals to vitamins and diagnostic products. The company develops and makes drugs to treat such life-threatening conditions as AIDS, cancer, and heart disease. The company also provides treatments for central nervous system and mental disorders (Valium), influenza (Tamiflu), and obesity (Xenical). Hoffmann-La Roche has collaborative agreements with deCODE genetics, Affymetrix, and Incyte Genomics to develop new drugs.

Company Address

340 Kingsland Street
Nutley, NJ 07110-1199
Phone: (973) 235-5000
Fax: (973) 235-7605
Website: http://www.rocheusa.com

Management Information

President & CEO
Mr. George Abercrombie

Company Information

Est. Revenue: $1000 Million
Employees: 6000

The contact, business and financial information provided above regarding Hoffmann-La Roche, Inc. is believed to be factual and up-to-date, but BB101 does not guarantee its accuracy. In some cases, estimated revenue has been calculated based on employee count and industry statistics. The information on these manufacturers and service companies may have changed recently so please contact the business itself for further information and data.

More Companies to Explore

Popular Companies